Loading insider details...
Beta
Latest Form 4 (Sep 23, 2025): Grant/Award of 1,700,000 CTOR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 23, 2025 | CITIUS ONCOLOGY, INC. (CTOR) | Grant/Award | 1,700,000 | n/a |
| Sep 23, 2025 | Citius Pharmaceuticals, Inc. (CTXR) | Disposition to Issuer | 125,490 | n/a |
| Dec 16, 2024 | CITIUS ONCOLOGY, INC. (CTOR) | Grant/Award | 800,000 | n/a |
| Nov 12, 2024 | Citius Pharmaceuticals, Inc. (CTXR) | Grant/Award | 600,000 | n/a |
| Sep 27, 2024 | Citius Pharmaceuticals, Inc. (CTXR) | Disposition to Issuer | 3,137,255 | n/a |
| Aug 14, 2024 | CITIUS ONCOLOGY, INC. (CTOR) | Grant/Award | 1,233,333 | n/a |
| Aug 12, 2024 | Tharimmune, Inc. (THAR) | Grant/Award | 2,353 | n/a |
| Apr 5, 2024 | Citius Pharmaceuticals, Inc. (CTXR) | Disposition to Issuer | 1,165,048 | n/a |
| Nov 10, 2023 | Tharimmune, Inc. (THAR) | Grant/Award | 25,000 | n/a |
| Oct 12, 2023 | Citius Pharmaceuticals, Inc. (CTXR) | Grant/Award | 550,000 | n/a |